Skip to Content

8 Results Found

  • Article
  • Open Access
15 Citations
4,321 Views
13 Pages

18 June 2023

Melanoma is the most invasive and lethal skin cancer. Recently, PD-1/PD-L1 pathway modulation has been applied to cancer therapy due to its remarkable clinical efficacy. SH003, a mixture of natural products derived from Astragalus membranaceus, Angel...

(This article belongs to the Special Issue Natural Products and Cancer)
  • Review
  • Open Access
99 Citations
13,877 Views
28 Pages

4 November 2021

CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described as highly selective for helper T type 2 (Th2) cells. Later, its expression wa...

(This article belongs to the Special Issue Emerging Roles of Chemokines in Cancer Immunotherapy)
  • Article
  • Open Access
10 Citations
4,547 Views
22 Pages

Design and Optimization of UAV Aerial Recovery System Based on Cable-Driven Parallel Robot

  • Jun Wu,
  • Yizhang Sun,
  • Honghao Yue,
  • Junyi Yang and ,
  • Fei Yang and
  • Yong Zhao
  • + 1 author+ 0 author

Aerial recovery and redeployment can effectively increase the operating radius and the endurance of unmanned aerial vehicles (UAVs). However, the challenge lies in the effect of the aerodynamic force on the recovery system, and the existing road-base...

(This article belongs to the Special Issue Bio-Inspired Flight Systems and Bionic Aerodynamics 2.0)
  • Article
  • Open Access
626 Views
19 Pages

Kujiol A Inhibits Interferon-γ and Interleukin-2 Expression and the NFATc2 Interaction with Their Promoters in T Cells

  • Tanpitcha Yodweerapong,
  • Rikako Yamaguchi,
  • Ayaka Nakao,
  • Sakihito Kitajima and ,
  • Tomoo Shiba,
  • Ken-ichi Kimura and
  • Takao Kataoka
  • + 2 authors+ 0 author

Kujiol A is one of the kujigamberol-related compounds isolated from Kuji amber. We previously demonstrated that kujiol A exhibited multiple biological activities, including the inhibition of Ca2+ signal transduction. In the present study, we found th...

(This article belongs to the Special Issue Bioactive Compounds as Modulators of Antioxidant Activity and Inflammatory Processes in Related Diseases)
  • Article
  • Open Access
11 Citations
4,377 Views
17 Pages

Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties

  • Romain Regnault,
  • Frédérique Klupsch,
  • Hassiba El-Bouazzati,
  • Romain Magnez and ,
  • Raphaël Le Biannic,
  • Natascha Leleu-Chavain,
  • Hania Ahouari,
  • Hervé Vezin,
  • Régis Millet and
  • Christian Bailly
  • + 7 authors+ 2 authors

15 April 2023

Orally-active anticancer small molecules targeting the PD-1/PD-L1 immune checkpoint are actively searched. Phenyl-pyrazolone derivatives with a high affinity for PD-L1 have been designed and characterized. In addition, the phenyl-pyrazolone unit acts...

(This article belongs to the Special Issue Design, Synthesis and Biological Activity of Novel Antitumor Drugs)
  • Article
  • Open Access
2 Citations
1,618 Views
15 Pages

Kujigamberol Inhibits IFN-γ and IL-2 mRNA Expression and NFATc2 Binding to Their Promoters in Response to a Phorbol Ester and Ionomycin Stimulation

  • Tanpitcha Yodweerapong,
  • Yuto Ueno,
  • Rikako Yamaguchi,
  • Piimwara Yarangsee and ,
  • Ken-ichi Kimura and
  • Takao Kataoka
  • + 1 author+ 0 author

Kujigamberol, a dinorlabdane compound isolated from Kuji amber, exerts multiple biological effects, including anti-allergic and anti-inflammatory activities. The present study demonstrated that kujigamberol inhibited cytokine production by T cells. I...

(This article belongs to the Special Issue Natural Products with Pharmaceutical Activities)
  • Article
  • Open Access
2 Citations
3,458 Views
13 Pages

IL-2K35C-moFA, a Long-Acting Engineered Cytokine with Decreased Interleukin 2 Receptor α Binding, Improved the Cellular Selectivity Profile and Antitumor Efficacy in a Mouse Tumor Model

  • Xiaoze Wang,
  • Gang Chen,
  • Lei Nie,
  • Zhenhua Wu and ,
  • Xinzeng Wang,
  • Chenxiao Pan,
  • Xuchen Chen,
  • Xiaobei Zhao,
  • Jie Zhu and
  • Haibin Wang
  • + 6 authors+ 1 author

28 September 2022

Human interleukin 2 (IL-2) has shown impressive results as a therapeutic agent for cancer. However, IL-2-based cancer therapy is limited by strong Treg amplification owing to its high binding affinity to IL-2 receptor α (IL-2Rα) and its s...

(This article belongs to the Collection Factors Regulating Cancer Cell Growth, Migration, Invasion, and Apoptosis)
  • Article
  • Open Access
7 Citations
3,095 Views
22 Pages

6 December 2023

Previous studies have demonstrated that extracellular vesicles (EVs) derived from an anaplastic mouse melanoma cell line made using Nanog overexpression of F10 (Nanog+F10) suppressed the metastasis of Nanog+F10. Here, an induced pluripotent stem (iPS...

(This article belongs to the Special Issue State-of-the-Art Cancer Immunotherapies)